📰 Genentech News
Page 135 - Genentech News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Genentech. Real-time updates on events, politics, business and more.
July 13, 2023
A study investigating a subcutaneous formulation of ocrelizumab (Ocrevus) met its primary and secondary endpoints in patients with multiple sclerosis.
July 12, 2023
Bridge to join as an industry member to advance the science of early detection and speed development of novel treatments SEONGNAM, South Korea and CAMBRIDGE, Mass., July 12, 2023 /PRNewswire/ -- Bridge Biotherapeutics (KQ288330), a South Korean clinical-stage biotech company developing novel drugs for fibrosis, cancer and inflammation, announced that it has joined PROLIFIC, the Prognostic Lung Fibrosis Consortium,...
July 12, 2023
The company just received a $50 million investment from Nvidia.
July 12, 2023
New York, NY (PRWEB) July 12, 2023 -- The Conference Forum announced the 13th annual PODD: Partnership Opportunities in Drug Delivery conference will take
July 11, 2023
The RET-mutant medullary thyroid cancer indication for Gavreto (pralsetinib) has been withdrawn by Genentech and Blueprint Medicines.
July 11, 2023
Adicet Bio, Inc. , a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer, today announced the appointment of Katie Peng to its Board of...
July 11, 2023
John Berylson, of Wellesley Hills, died on July 4, 2023.
July 11, 2023
EQS-News: ABIVAX / Key word: Personnel Abivax announces the appointment of June Lee, M.D. and Troy Ignelzi as Members of the Board of Directors 11.07.2023 /...
July 11, 2023
PARIS, FRANCE / ACCESSWIRE / July 11, 2023 / Abivax SA (PARIS:FR), a Phase 3 clinical-stage biotechnology company focused on developing therapeutics that modulate the immune system to treat patients with chronic
July 11, 2023
EQS-News: ABIVAX / Key word(s): Personnel Abivax announces the appointment of June Lee, M.D. and Troy Ignelzi as M...